FDA warns of another compounding pharmacy recall

by Matthew Perrone

BY MATTHEW PERRONE AP HEALTH WRITER WASHINGTON (AP) – The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients. The FDA said Wednesday that Clinical Specialties of Martinez, Ga. has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder in seniors.
The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since December 18, the FDA said in an online posting. Avastin is approved as a cancer drug, but it contains the same active ingredient as Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors. Repackaged injections of Avastin cost about $50, compared with $2,000 for Lucentis. A call placed to Clinical Specialties' lead pharmacist, Austin Gore, was not immediately returned Wednesday. Swiss drugmaker Roche has tried to discourage doctors from using Avastin for such unapproved uses. The company points out that Lucentis was specifically tested and formulated for use in the eye, and its price reflects the cost of that research and development. However, groups like the American Academy of Ophthalmologists say there is no detectable difference in outcomes for patients. More than half the injections given for macular generation in the U.S. are Avastin, according to the group. Age-related macular degeneration is the most common cause of blindness among older Americans, affecting about 2 million people in the U.S. over age 50. The condition causes new blood vessels to grow in the eye and leak blood and fluid, damaging the retina and distorting vision. In recent weeks the FDA has stepped up inspections of compounding pharmacies across a dozen states after a fungal meningitis outbreak last year tied to compounded drugs. A tainted steroid distributed by a Massachusetts-based compounding pharmacy killed 50 people and has sickened more than 720 nationwide. Many of the cases involved a rare form of meningitis tied to fungus found in the New England Compounding Center's facilities. The company has been shut down since the outbreak was discovered in September. ---- © 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


More Local

10 Things to Know for Today

Your daily look at late-breaking news, upcoming events and the stories that will be talked about today: 1. ARRESTS, TEAR GAS MAR FERGUSON NI ... Read More


Dollar General enters bidding for Family Dollar

GOODLETTSVILLE, Tenn. (AP) — There's now a bidding war for Family Dollar, with Dollar General offering about $9.7 billion for the disc ... Read More


US jobless aid applications rise to 311,000

WASHINGTON (AP) — More people applied for U.S. unemployment benefits last week, although jobless claims continue to be close to pre-r ... Read More


Locals recall, mourn actor Robin Williams

Millions have watched Robin Williams’ performances on both the large and small screen – and laughed at his antics as Mork or as ... Read More


Erasing the stigma of depression

Williams’ illness, suicide sparks national dialogue

In the aftermath of actor and comedian Robin Williams’ suicide, a national dialogue has been sparked about depression and the many mis ... Read More

Addiction in Coweta Community

Resources available for recovery

Editor’s note: This is the fourth and last installment in a Sunday series on the spread of drug addiction, including prescription pill ... Read More